# A Study to Evaluate a Computerized Stethoscope Called ©Voqx to Diagnose Heart Disease

Study · id `cardio:ct-nct04960280` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04960280](<https://clinicaltrials.gov/study/NCT04960280>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT04960280

Browse, organ or system: Heart  
Browse, condition area: Heart failure; Valve and congenital heart disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 400 participants.

## Technical summary

Registry record NCT04960280. Allocation not applicable; no masking; primary purpose diagnostic. Start 2021-09-03 (actual); primary completion 2024-05-02 (actual). Results posted on 2026-10-20.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose diagnostic
- Phase: Not applicable
- Enrolled: 400 participants (enrolled count; ClinicalTrials.gov record NCT04960280, source copy `cardio:ctgov-nct04960280-2026-10-20`, retrieved 2026-10-26)
- Started: 2021-09-03 (actual) (ClinicalTrials.gov record NCT04960280, source copy `cardio:ctgov-nct04960280-2026-10-20`, retrieved 2026-10-26)
- Primary completion: 2024-05-02 (actual) (ClinicalTrials.gov record NCT04960280, source copy `cardio:ctgov-nct04960280-2026-10-20`, retrieved 2026-10-26)
- Completion: 2025-12-17 (actual) (ClinicalTrials.gov record NCT04960280, source copy `cardio:ctgov-nct04960280-2026-10-20`, retrieved 2026-10-26)
- Results first posted: 2026-10-20 (ClinicalTrials.gov record NCT04960280, source copy `cardio:ctgov-nct04960280-2026-10-20`, retrieved 2026-10-26)
- Countries: United States (ClinicalTrials.gov record NCT04960280, source copy `cardio:ctgov-nct04960280-2026-10-20`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04960280-2026-10-20`, retrieved 2026-10-26)

## The registry's words

- Brief title: A Study to Evaluate a Computerized Stethoscope Called ©Voqx to Diagnose Heart Disease
- Condition: Isolated Aortic Stenosis
- Condition: Mitral Regurgitation
- Intervention (Device): ©VoqX stethoscope
- Lead sponsor: Mayo Clinic
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Heart valve disease (`cardio:heart-valve-disease`)
- Registry condition terms include this condition: Mitral regurgitation (`cardio:mitral-regurgitation`)
- Registry lists this organization as the lead sponsor: Mayo Clinic (`cardio:org-mayo-clinic`)

## Provenance

Content hash: e88cb8a4209eb2a7d5a040e78e66057561e69613299369e7c5cd16cf168fc7fc
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
